NAMS Shares

Business

What Do Analysts Say About NewAmsterdam Pharma Company NV (NAMS)?

Cody Benson

NewAmsterdam Pharma Company NV (NAMS) saw an uptrend of 2.40% in the recent trading with $32.41 being its most recent. ...

Companies

What Do Analysts Say About NewAmsterdam Pharma Company NV (NAMS)?

Heidi Phillips

NewAmsterdam Pharma Company NV (NAMS) saw downtrend of -0.28% in the recent trading with $31.83 being its most recent. The ...

Business

NewAmsterdam Pharma Company NV (NAMS):Buy today, is the recommendation of the stock’s medium term indicators

Cody Benson

NewAmsterdam Pharma Company NV (NAMS) saw an uptrend of 4.20% in the recent trading with $35.45 being its most recent. ...

Value Stocks

NewAmsterdam Pharma Company NV (NAMS): The stock medium term indicators show it’s time to Buy

Noah Smith

NewAmsterdam Pharma Company NV (NAMS) saw an uptrend of 0.98% in the recent trading with $35.08 being its most recent. ...

Baxter Report
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.